Mga Batayang Estadistika
LEI | 213800JJ6CRPCWCQVZ25 |
CIK | 1656081 |
SEC Filings
SEC Filings (Chronological Order)
September 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 20-F (Mark One) ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934 For the fiscal year ended June 30, 2025 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF |
|
September 4, 2025 |
Exhibit 12.1 Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, John Cotterell, certify that: 1. I have reviewed this annual report on Form 20-F of ENDAVA PLC (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a materia |
|
September 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of September 2025 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the |
|
September 4, 2025 |
Exhibit 13.1 Certification by the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 |
|
September 4, 2025 |
earningspresentationq4fy © Copyright 2025 Endava Investor presentation Q4 FY2025 © Copyright 2025 Endava Disclaimer This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
September 4, 2025 |
As filed with the U.S. Securities and Exchange Commission on September 4, 2025 As filed with the U.S. Securities and Exchange Commission on September 4, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENDAVA PLC (Exact name of registrant as specified in its charter) England and Wales Not applicable (State or other jurisdiction of incorporation or organization) |
|
September 4, 2025 |
Exhibit 12.2 Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Mark Thurston, certify that: 1. I have reviewed this annual report on Form 20-F of ENDAVA PLC (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material |
|
September 4, 2025 |
Table 1: Newly Registered Securities Calculation of Filing Fee Tables S-8 Endava plc Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Class A ordinary shares Other 1,189,811 $ 14. |
|
September 4, 2025 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-229213) and Form S-8 (Nos. 333-228717, 333-248904, 333-259900, 333-268067, 333-274571, 333-282207) of Endava plc of our report dated September 4, 2025 relating to the financial statements and the effectiveness of internal cont |
|
September 4, 2025 |
exhibit46-2018sharesavep 309733606 v2 ENDAVA 2018 SHARESAVE PLAN Adopted by the Board on 16 April 2018 and approved by Shareholders on 3 May 2018 Amended by the Board September 2020 Further amended by the Board effective 1 March 2025 309733606 v2 -2- Table of Contents Page 1. |
|
September 4, 2025 |
Q4 FY2025 & FY2025 ENDAVA ANNOUNCES FOURTH QUARTER FISCAL YEAR 2025 & FISCAL YEAR 2025 RESULTS Q4 FY2025 3. |
|
July 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of July 2025 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the regis |
|
July 8, 2025 |
Endava Strengthens Executive Team London, UK, July 8, 2025 – Endava plc (NYSE: DAVA), a leading next-generation technology services provider, today announces changes to its executive team. |
|
May 14, 2025 |
Investor presentation Q3 FY2025 Disclaimer This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
May 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2025 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the regist |
|
May 14, 2025 |
Q3 FY2025 ENDAVA ANNOUNCES THIRD QUARTER FISCAL YEAR 2025 RESULTS Q3 FY2025 11.7% Year on Year Revenue Increase to £194.8 million 12.4% Revenue Increase at Constant Currency Diluted EPS £0.18 compared to £(0.03) in the prior year comparative period Adjusted Diluted EPS £0.34 compared to £0.22 in the prior year comparative period London, U.K. – Endava plc (NYSE: DAVA) ("Endava" or the "Company"), t |
|
March 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of March 2025 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the regi |
|
March 28, 2025 |
315973966 v4 1 The following risk factors update and supplement, and should be read together with, the risk factors previously provided under “Risk Factors” in Part I, Item 3. |
|
March 28, 2025 |
ENDAVA PLC CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) For the six months ended December 31, 2024 and 2023 Six Months Ended December 31 2024 2023 Note £’000 £’000 REVENUE 5 390,641 371,973 Cost of sales Direct cost of sales (283,066) (259,412) Allocated cost of sales (13,898) (13,218) Total cost of sales (296,964) (272,630) GROSS PROFIT 93,677 99,343 Selling, general and |
|
March 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of March 2025 Commission File Number: 001-38607 ENDAVA PLC (Translation of registrant’s name into English) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by |
|
February 20, 2025 |
q2fy25irdeck1 |
|
February 20, 2025 |
e664214endavacardclean General Meeting Endava plc (the “Company”) ADS CUSIP No.: 29260V105.* ADS Record Date: 5:00 P.M. (New York City time) on February 14, 2025. Meeting Specifics: General Meeting to be held on Friday, March 14, 2025 at 2:00 P.M. (London time) at the offices of Cooley (UK) LLP, 22 Bishopsgate, London EC2N 4BQ, United Kingdom. Meeting Agenda: Please note that the Company’s Notice |
|
February 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of February 2025 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
February 20, 2025 |
Class A Ordinary Shares Beneficially Owned# THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to the action to be taken, please seek your own financial advice from your stockbroker, solicitor, accountant or other appropriately authorised independent financial adviser. If you have recently sold or transferred all of your shares in Endava plc (“Endava”, or the “Company”) you should forward this docum |
|
February 20, 2025 |
Q2 FY2025 ENDAVA ANNOUNCES SECOND QUARTER FISCAL YEAR 2025 RESULTS Q2 FY2025 6.6% Year on Year Revenue Increase to £195.6 million 9.1% Revenue Increase at Constant Currency Diluted EPS £0.11 compared to £0.14 in the prior comparative period Adjusted Diluted EPS £0.30 unchanged from the prior comparative period Endava announces $100 million share repurchase program London, U.K. – Endava plc (NYSE: |
|
February 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of February 2025 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
February 20, 2025 |
ADSs: American Depositary Shares. ADS CUSIP No.: 29260V105.* ADS Record Date: 5:00 P.M. (New York City time) on February 14, 2025. Meeting Specifics: General Meeting to be held on Friday, March 14, 2025 at 2:00 P.M. (London time) at the offices of Cooley (UK) LLP, 22 Bishopsgate, London EC2N 4BQ, United Kingdom (the "General Meeting"). Meeting Agenda: Please note that the Company’s Notice of Gener |
|
January 7, 2025 |
AGREEMENT JOINT FILING OF SCHEDULE 13G AGREEMENT JOINT FILING OF SCHEDULE 13G Kayne Anderson Rudnick Investment Management, LLC (an investment adviser registered under the Investment Advisers Act of 1940), and Virtus Investment Advisers, LLC (an investment adviser registered under the Investment Advisers Act of 1940) and Virtus Equity Trust (on behalf of Virtus KAR Small-Cap Growth Fund), a Delaware statutory trust, hereby agree to file jointly the statement on Schedule 13G to which this Agreement is attached, and any amendments thereto which may be deemed necessary, pursuant to Regulation 13D-G under the Securities Exchange Act of 1934. |
|
December 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of December 2024 Commission File Number: 001-38607 ENDAVA PLC (Translation of registrant’s name into English) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate |
|
November 13, 2024 |
SC 13G/A 1 fp0090889-18sc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 1)* ENDAVA PLC (Name of Issuer) American Depositary Shares Representing Ordinary Shares (Title of Class of Securities) 29260 |
|
November 13, 2024 |
SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Endava PLC (Name of Issuer) Common Stock (Title of Class of Securities) 29260V105 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa |
|
November 12, 2024 |
Q1 FY2025 ENDAVA ANNOUNCES FIRST QUARTER FISCAL YEAR 2025 RESULTS Q1 FY2025 3.5% Year on Year Revenue Increase to £195.1 million 5.2% Revenue Increase at Constant Currency Diluted EPS £0.04 compared to £0.21 in the prior comparative period Adjusted Diluted EPS £0.25 compared to £0.39 in the prior comparative period London, U.K. – Endava plc (NYSE: DAVA) ("Endava" or the "Company"), a leading techn |
|
November 12, 2024 |
Exhibit 99.1 THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to the action to be taken, please seek your own financial advice from your stockbroker, solicitor, accountant or other appropriately authorised independent financial adviser. If you have recently sold or transferred all of your shares in Endava plc (“Endava”, or the “Company”) you should forwa |
|
November 12, 2024 |
Investor presentation Q1 FY2025 Disclaimer This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2024 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
November 12, 2024 |
Exhibit 99.4 Annual General Meeting The Voting Instructions must be signed, completed and received at the indicated address prior to 10:00 A.M. (New York City time) on December 9, 2024 for action to be taken. 2024 VOTING INSTRUCTIONS AMERICAN DEPOSITARY SHARES Endava plc (the “Company”) ADS CUSIP No.: 29260V105.* ADS Record Date: 5:00 P.M. (New York City time) on November 6, 2024. Meeting Specific |
|
November 12, 2024 |
Exhibit 99.2 ENDAVA PLC - Annual General Meeting 2024 - Form of Proxy You may appoint a proxy at www.signalshares.com instead of using this form. Account Name: as my/our proxy, to attend, speak and vote on my/our behalf at the Meeting of the Company and at any adjournment thereof. Please indicate below how you would like your proxy to vote on your behalf on the resolutions. Please put an ‘X’ in th |
|
November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2024 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
November 12, 2024 |
Exhibit 99.3 Time Sensitive Materials Depositary’s Notice of Annual General Meeting of Endava plc (the “Company”) ADSs: American Depositary Shares. ADS CUSIP No.: 29260V105.* ADS Record Date: 5:00 P.M. (New York City time) on November 6, 2024. Meeting Specifics: Annual General Meeting to be held on Thursday, December 12, 2024 at 2:30 P.M. (London time) at the offices of Cooley (UK) LLP, 22 Bisho |
|
November 6, 2024 |
EX-99 2 Rule13DJointFilingAgreement.htm JOINT FILING AGREEMENT JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) (l) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing of the attached Schedule 13G, and any and all amendments thereto, and expressly authorize Invesco Ltd., as the ultimate parent company of each of its undersigned subsidiarie |
|
November 6, 2024 |
SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Endava PLC (Name of Issuer) American Depository Receipt (Title of Class of Securities) 29260V105 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
September 19, 2024 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-229213) and Form S-8 (Nos. 333-228717, 333-248904, 333-259900, 333-268067, 333-274571) of Endava plc of our report dated September 19, 2024 relating to the financial statements and the effectiveness of internal control over fi |
|
September 19, 2024 |
Internal use only endava.com INCENTIVE COMPENSATION RECOUPMENT POLICY ENDAVA PLC | NOVEMBER 2023 Internal use only 2 INCENTIVE COMPENSATION RECOUPMENT POLICY Endava Plc | NOVEMBER 2023 CONTENTS 1 INTRODUCTION ......................................................................... 3 2 EFFECTIVE DATE ...................................................................... 3 3 DEFINITIONS ........... |
|
September 19, 2024 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Endava plc (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title(1) Fee Calculation Rule Amount Registered(2) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Class A ordinary shares, nominal value £0. |
|
September 19, 2024 |
Consent of Independent Registered Public Accounting Firm Exhibit 15.2 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the registration statements (No. 333-229213 on Form F-3, and No. 333-268067, 333-228717, 333-248904, 333-259900 and 333-274571 on Form S-8) of our report dated October 31, 2022, with respect to the consolidated financial statements of Endava plc. /s/ KPMG LLP London, United Kingdom |
|
September 19, 2024 |
Exhibit 12.2 Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Mark Thurston, certify that: 1. I have reviewed this annual report on Form 20-F of ENDAVA PLC (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material |
|
September 19, 2024 |
Exhibit 13.1 Certification by the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 |
|
September 19, 2024 |
As filed with the U.S. Securities and Exchange Commission on September 19, 2024 As filed with the U.S. Securities and Exchange Commission on September 19, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENDAVA PLC (Exact name of registrant as specified in its charter) England and Wales Not applicable (State or other jurisdiction of incorporation or organization) |
|
September 19, 2024 |
endava.com Share Dealing Code Endava PLC | August 2024 Share Dealing Code Endava PLC | August 2024 2 Contents 1 Introduction ....................................................................................................... 3 2 Purpose of Code ............................................................................................... 3 3 Persons Subject to This Code ...................... |
|
September 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 20-F (Mark One) ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934 For the fiscal year ended June 30, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF |
|
September 19, 2024 |
Q4 FY2024 & FY2024 ENDAVA ANNOUNCES FOURTH QUARTER FISCAL YEAR 2024 & FISCAL YEAR 2024 RESULTS Q4 FY2024 2. |
|
September 19, 2024 |
Investor presentation Q4 FY2024 3 This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
September 19, 2024 |
ENDAVA PLC ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024 COMPANY REGISTRATION NUMBER 05722669 Docusign Envelope ID: 891214E1-7FAC-45C3-AC47-AAB3176B9FC0 COMPANY REGISTRATION NUMBER 05722669 REGISTERED OFFICE 125 Old Broad Street LONDON EC2N 1AR DIRECTORS T A Smith (Non-Executive Chairman) J E Cotterell (Chief Executive Officer) M S Thurston (Chief Financial Officer) S Conn |
|
September 19, 2024 |
Certain information indicted by [***] has been omitted from this exhibit because its both not material and is the type the Company treats as private or confidential. |
|
September 19, 2024 |
Exhibit 12.1 Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, John Cotterell, certify that: 1. I have reviewed this annual report on Form 20-F of ENDAVA PLC (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a materia |
|
September 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of September 2024 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the |
|
May 23, 2024 |
Q3 FY2024 ENDAVA ANNOUNCES THIRD QUARTER FISCAL YEAR 2024 RESULTS Q3 FY2024 14.3% Year on Year Revenue Decrease to £174.4 million 11.8% Revenue Decrease at Constant Currency Diluted EPS £(0.03) compared to £0.42 in the prior year comparative period Adjusted diluted EPS £0.22 compared to £0.59 in the prior year comparative period London, U.K. – Endava plc (NYSE: DAVA) ("Endava" or the "Company"), a |
|
May 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2024 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the regist |
|
May 23, 2024 |
earningspresentationq3fy Investor presentation Q3 FY2024 3 This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
April 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 1)* ENDAVA PLC (Name of Issuer) American Depositary Shares Representing Ordinary Shares (Title of Class of Securities) 29260V105 (CUSIP Number) March 31, 2024 |
|
March 29, 2024 |
DAVA / Endava plc - Depositary Receipt (Common Stock) / Cotterell John - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 5)* Endava plc (Name of Issuer) Class A ordinary shares, nominal value £0.02 per ordinary share (Title of Class of Securities) 29260V105** (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropria |
|
March 27, 2024 |
ENDAVA PLC CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) For the six months ended December 31, 2023 and 2022 Six Months Ended December 31 2023 2022(1) Note £’000 £’000 REVENUE 5 371,973 401,410 Cost of sales Direct cost of sales (259,412) (249,253) Allocated cost of sales (13,218) (12,243) Total cost of sales (272,630) (261,496) GROSS PROFIT 99,343 139,914 Selling, general |
|
March 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of March 2024 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the regi |
|
February 29, 2024 |
Q2 FY2024 ENDAVA ANNOUNCES SECOND QUARTER FISCAL YEAR 2024 RESULTS Q2 FY2024 10.6% Year on Year Revenue Decrease to £183.6 million 8.1% Revenue Decrease at Constant Currency Diluted EPS £0.14 compared to £0.26 in the prior year comparative period Adjusted diluted EPS £0.30 compared to £0.59 in the prior year comparative period London, U.K. – Endava plc (NYSE: DAVA) ("Endava" or the "Company"), a l |
|
February 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of February 2024 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
February 29, 2024 |
endava-galaxefinalfeb292 Endava to Acquire GalaxE Solutions to Boost its Position in North America Healthcare with Delivery from India London, UK; February 29, 2024 – Endava (NYSE: DAVA), a leading technology services company combining world-class engineering, industry expertise and a people-centric mindset, has entered into a definitive agreement to acquire 100% ownership of GalaxE Group, Inc. |
|
February 29, 2024 |
q2fy24irdeck26feb Investor presentation Q2 FY2024 3 This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
February 14, 2024 |
DAVA / Endava plc - Depositary Receipt (Common Stock) / BAMCO INC /NY/ - NONE Passive Investment SC 13G/A 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 05)* Endava plc (Name of Issuer) AMERICAN DEPOSITARY SHARES (Title of Class of Securities) 29260V105*** (CUSIP Number) Calendar Year 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate |
|
February 13, 2024 |
AGREEMENT JOINT FILING OF SCHEDULE 13G EX-1 2 fp0086862-54ex1.htm AGREEMENT JOINT FILING OF SCHEDULE 13G Kayne Anderson Rudnick Investment Management, LLC (an investment adviser registered under the Investment Advisers Act of 1940), and Virtus Investment Advisers, Inc. (an investment adviser registered under the Investment Advisers Act of 1940), hereby agree to file jointly the statement on Schedule 13G to which this Agreement is attac |
|
February 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. n/a)* ENDAVA PLC (Name of Issuer) American Depositary Shares Representing Ordinary Shares (Title of Class of Securities) 29260V105 (CUSIP Number) December 31, |
|
February 9, 2024 |
SC 13G 1 a53894615.htm GRANDEUR PEAK GLOBAL ADVISORS, LLC SC 13G - ENDAVA PLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Endava PLC (Name of Issuer) American Depository Shares (Title of Class of Securities) 29260V105* (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the |
|
February 9, 2024 |
SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Endava PLC (Name of Issuer) Common Stock (Title of Class of Securities) 29260V105 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th |
|
December 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of December 2023 Commission File Number: 001-38607 ENDAVA PLC (Translation of registrant’s name into English) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate |
|
November 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2023 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
November 15, 2023 |
Q1 FY2024 ENDAVA ANNOUNCES FIRST QUARTER FISCAL YEAR 2024 RESULTS Q1 FY2024 3.9% Year on Year Revenue Decrease to £188.4 million 0.6% Revenue Decrease at Constant Currency Diluted EPS £0.21 compared to £0.55 in the prior year comparative period Adjusted diluted EPS £0.39 compared to £0.54 in the prior year comparative period London, U.K. – Endava plc (NYSE: DAVA) ("Endava" or the "Company"), a glo |
|
November 15, 2023 |
irq1fy24x14nov Q1 FY2024 INVESTOR PRESENTATION 2 This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
November 13, 2023 |
Annual General Meeting The Voting Instructions must be signed, completed and received at the indicated address prior to 10:00 A. |
|
November 13, 2023 |
Endava plc - Annual General Meeting 2023 (the "AGM") - Form of Proxy You may appoint a proxy at www. |
|
November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2023 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
November 13, 2023 |
Class A Ordinary Shares Beneficially Owned THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to the action to be taken, please seek your own financial advice from your stockbroker, solicitor, accountant or other appropriately authorised independent financial adviser. If you have recently sold or transferred all of your shares in Endava plc (“Endava”, or the “Company”) you should forward this docum |
|
November 13, 2023 |
Depositary’s Notice of Annual General Meeting of Endava plc (the “Company”) Depositary’s Notice of Annual General Meeting of Endava plc (the “Company”) ADSs: American Depositary Shares. |
|
September 19, 2023 |
Exhibit 12.1 Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, John Cotterell, certify that: 1. I have reviewed this annual report on Form 20-F of ENDAVA PLC (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a materia |
|
September 19, 2023 |
As filed with the U.S. Securities and Exchange Commission on September 19, 2023 As filed with the U.S. Securities and Exchange Commission on September 19, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENDAVA PLC (Exact name of registrant as specified in its charter) England and Wales Not applicable (State or other jurisdiction of incorporation or organization) |
|
September 19, 2023 |
irdeckq4fy2315sep23 Q4 FY2023 INVESTOR PRESENTATION 2 This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
September 19, 2023 |
signedukplcstats ENDAVA PLC ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2023 COMPANY REGISTRATION NUMBER 5722669 DocuSign Envelope ID: 10651093-803F-4868-812D-96F4738D9B9A COMPANY REGISTRATION NUMBER 5722669 REGISTERED OFFICE 125 Old Broad Street LONDON EC2N 1AR DIRECTORS T A Smith (Non-Executive Chairman) J E Cotterell (Chief Executive Officer) M S Thurston (Chief Financial |
|
September 19, 2023 |
Exhibit 12.2 Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Mark Thurston, certify that: 1. I have reviewed this annual report on Form 20-F of ENDAVA PLC (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material |
|
September 19, 2023 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Endava plc (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Security Type Security Class Title(1) Fee Calculation Rule Amount Registered(2) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Class A ordinary shares, nominal value £0. |
|
September 19, 2023 |
Consent of Independent Registered Public Accounting Firm Exhibit 15.2 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the registration statements (No. 333-229213 on Form F-3, and No. 333-268067, 333-228717, 333-248904 and 333-259900 on Form S-8) of our report dated October 31, 2022 with respect to the consolidated financial statements of Endava plc. /s/ KPMG LLP London, United Kingdom September 19 |
|
September 19, 2023 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-229213) and Form S-8 (Nos. 333-268067, 333-228717, 333-248904, 333-259900) of Endava plc of our report dated September 19, 2023 relating to the financial statements and the effectiveness of internal control over financial repo |
|
September 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 20-F (Mark One) ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934 For the fiscal year ended June 30, 2023 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF |
|
September 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of September 2023 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the |
|
September 19, 2023 |
Exhibit 13.1 Certification by the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 |
|
September 19, 2023 |
Q4 FY2023 & FY2023 ENDAVA ANNOUNCES FOURTH QUARTER FISCAL YEAR 2023 & FISCAL YEAR 2023 RESULTS Q4 FY2023 5. |
|
August 3, 2023 |
Endava Acquires TLM to Boost its Position in Digital Entertainment London, UK, August 3, 2023, (NYSE “DAVA”) – Endava, a global provider of digital transformation, agile development and intelligent automation services, announced today the acquisition of TLM Partners, Inc together with its subsidiaries (“TLM” or the “Monsters”). |
|
August 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of August 2023 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the reg |
|
June 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of June 2023 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the regis |
|
June 9, 2023 |
dove6kfinal9june2023 Endava Continues Asia Pacific Expansion, Announcing the Acquisition of DEK London, UK, June 9, 2023, (NYSE “DAVA”) – Endava, a pure play next-gen technology company, announced today the acquisition of DEK Corporation Pty Ltd, DEK Technologies Sweden AB and DEK Vietnam Company Ltd (collectively, “DEK”), a multinational firm that develops cutting-edge software and hardware solutions across a range of applications, including embedded systems, real-time solutions, telecoms and data communications. |
|
May 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2023 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the regist |
|
May 23, 2023 |
irq3fy23x22may23 Q3 FY2023 INVESTOR PRESENTATION 2 This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
May 23, 2023 |
Q3 FY2023 ENDAVA ANNOUNCES THIRD QUARTER FISCAL YEAR 2023 RESULTS Q3 FY2023 20.3% Year on Year Revenue Growth to £203.5 million 14.6% Revenue Growth at Constant Currency IFRS diluted EPS £0.42 compared to £0.35 in the prior year comparative period Adjusted diluted EPS £0.59 compared to £0.48 in the prior year comparative period London, U.K. – Endava plc (NYSE: DAVA) ("Endava" or the "Company") a g |
|
May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2023 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the regist |
|
May 10, 2023 |
moonstoneexhibit Endava Announces the Acquisition of Mudbath, Australia London, UK, May 10, 2023, (NYSE “DAVA”) – Endava announced today the acquisition of Mudbath & Co. |
|
May 2, 2023 |
pressreleasepatrickbutch ENDAVA ANNOUNCES NEW MEMBER OF BOARD OF DIRECTORS & MANAGEMENT UPDATES London, UK (May 2, 2023) – Endava plc (NYSE: DAVA), a leading next-generation technology service provider, announced today the appointment of Patrick Butcher to its Board of Directors. |
|
May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2023 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the regist |
|
March 21, 2023 |
ENDAVA PLC CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) For the six months ended December 31, 2022 and 2021 Six Months Ended December 31 2022 2021 Note £’000 £’000 REVENUE 5 401,410 305,133 Cost of sales Direct cost of sales (249,253) (189,292) Allocated cost of sales (12,243) (11,090) Total cost of sales (261,496) (200,382) GROSS PROFIT 139,914 104,751 Selling, general an |
|
March 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of March 2023 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the regi |
|
February 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of February 2023 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
February 14, 2023 |
DAVA / Endava PLC - ADR / BAMCO INC /NY/ - NONE Passive Investment SC 13G/A 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 04)* Endava plc (Name of Issuer) AMERICAN DEPOSITARY SHARES (Title of Class of Securities) 29260V105*** (CUSIP Number) Calendar Year 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate |
|
February 14, 2023 |
Q2 FY2023 INVESTOR PRESENTATION 2 This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
February 14, 2023 |
Q2 FY2023 ENDAVA ANNOUNCES SECOND QUARTER FISCAL YEAR 2023 RESULTS Q2 FY2023 30.2% Year on Year Revenue Growth to £205.2 million 23.4% Revenue Growth at Constant Currency IFRS diluted EPS £0.26 compared to £0.27 in the prior year comparative period Adjusted diluted EPS £0.57 compared to £0.46 in the prior year comparative period London, U.K. – Endava plc (NYSE: DAVA) ("Endava" or the "Company") a |
|
February 13, 2023 |
DAVA / Endava PLC - ADR / Cotterell John - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 4)* Endava plc (Name of Issuer) Class A ordinary shares, nominal value £0.02 per ordinary share (Title of Class of Securities) 29260V105** (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
February 13, 2023 |
DAVA / Endava PLC - ADR / Grandeur Peak Global Advisors, LLC Passive Investment SC 13G 1 a53315034.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Endava PLC (Name of Issuer) American Depository Shares (Title of Class of Securities) 29260V105* (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic |
|
February 9, 2023 |
Endava Announces £350 Million Revolving Credit Facility Exhibit 99.1 Endava Announces £350 Million Revolving Credit Facility London— Endava (NYSE: DAVA): Endava plc (“Endava” or the “Company”) today announced the successful closing of a £350 million unsecured, multicurrency revolving credit facility (the “Multicurrency Revolving Credit Facility”). This facility is for general business purposes, including future capital investments and development activ |
|
February 9, 2023 |
Exhibit 99.2 EXECUTION VERSION Multicurrency Revolving Facility Agreement between Endava Plc as Company The Companies set out herein as Original Borrowers and Original Guarantors Banco Bilbao Vizcaya Argentaria, S.A., London Branch DNB (UK) Limited Fifth Third Bank, National Association HSBC UK Bank plc KeyBank National Association National Westminster Bank PLC as Mandated Lead Arrangers and Bookr |
|
February 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of February 2023 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
December 13, 2022 |
6-K 1 endavaagm2022results6k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of December 2022 Commission File Number: 001-38607 ENDAVA PLC (Translation of registrant’s name into English) 125 Old Broad Street London EC2N 1AR (Address of |
|
December 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of December 2022 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
December 13, 2022 |
Letter from KPMG LLP to the Securities and Exchange Commission, dated December 13, 2022 Exhibit 15.1 Letter from KPMG LLP to the Securities and Exchange Commission December 13, 2022 Securities and Exchange Commission Washington, D.C. 20549 Ladies and Gentlemen: We were previously principal accountants for Endava plc and, under the date of October 31, 2022, we reported on the consolidated financial statements of Endava plc and subsidiaries as of and for the years ended June 30, 2022, |
|
November 23, 2022 |
74,610 American Depositary Shares REPRESENTING 74,610 CLASS A ORDINARY SHARES Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-229213 PROSPECTUS 74,610 American Depositary Shares REPRESENTING 74,610 CLASS A ORDINARY SHARES The Endava Limited Guernsey Employee Benefit Trust, or the EBT, is offering 74,610 American Depositary Shares, or ADSs. Each ADS represents one Class A Ordinary Share. The ADSs may be evidenced by American Depositary Receipts, or AD |
|
November 15, 2022 |
Q1 FY2023 INVESTOR PRESENTATION 2 This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
November 15, 2022 |
Depositary’s Notice of Annual General Meeting of Endava plc (the “Company”) Depositary?s Notice of Annual General Meeting of Endava plc (the ?Company?) ADSs: American Depositary Shares. |
|
November 15, 2022 |
Q1 FY2023 ENDAVA ANNOUNCES FIRST QUARTER FISCAL YEAR 2023 RESULTS Q1 FY2023 33.0% Year on Year Revenue Growth to ?196.2 million 25.9% Revenue Growth at Constant Currency IFRS diluted EPS ?0.55 compared to ?0.36 in the prior year comparative period Adjusted diluted EPS ?0.54 compared to ?0.49 in the prior year comparative period London, U.K. ? Endava plc (NYSE: DAVA) ("Endava" or the "Company") a g |
|
November 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2022 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
November 15, 2022 |
Annual General Meeting The Voting Instructions must be signed, completed and received at the indicated address prior to 10:00 A. |
|
November 15, 2022 |
Class A Ordinary Shares Beneficially Owned THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to the action to be taken, please seek your own financial advice from your stockbroker, solicitor, accountant or other appropriately authorised independent financial adviser. If you have recently sold or transferred all of your shares in Endava plc (?Endava?, or the ?Company?) you should forward this docum |
|
November 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2022 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
November 10, 2022 |
Power of Attorney (included on the signature page hereto ). Table of Contents As filed with the Securities and Exchange Commission on November 10, 2022. |
|
October 31, 2022 |
Consent of KPMG LLP, independent registered public accounting firm Exhibit 15.1 Consent of Independent Registered Public Accounting Firm The Board of Directors Endava plc: We consent to the incorporation by reference in the registration statements (Nos. 333-228717, 333-248904 and 333-259900) on Form S-8 of our reports dated October 31, 2022, with respect to the consolidated financial statements of Endava plc and the effectiveness of internal control over financia |
|
October 31, 2022 |
Exhibit 12.2 Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Mark Thurston, certify that: 1. I have reviewed this annual report on Form 20-F of ENDAVA PLC (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material |
|
October 31, 2022 |
ENDAVA ANNOUNCES NEW MEMBER OF BOARD OF DIRECTORS ENDAVA ANNOUNCES NEW MEMBER OF BOARD OF DIRECTORS London, UK (October 31, 2022) ? Endava plc (NYSE: DAVA), a leading next-generation technology service provider, announced today the appointment of Kathryn Hollister to its Board of Directors. |
|
October 31, 2022 |
As filed with the U.S. Securities and Exchange Commission on October 31, 2022 As filed with the U.S. Securities and Exchange Commission on October 31, 2022 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENDAVA PLC (Exact name of registrant as specified in its charter) England and Wales Not applicable (State or other jurisdiction of incorporation or organization) ( |
|
October 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of October 2022 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the re |
|
October 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 20-F (Mark One) ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934 For the fiscal year ended June 30, 2022 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF |
|
October 31, 2022 |
Exhibit 13.1 Certification by the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 |
|
October 31, 2022 |
Letter from KPMG LLP to the Securities and Exchange Commission, dated Exhibit 15.2 Letter from KPMG LLP to the Securities and Exchange Commission October 31, 2022 Securities and Exchange Commission Washington, D.C. 20549 Ladies and Gentlemen: We are currently principal accountants for Endava plc and, under the date of October 31, 2022, we reported on the consolidated financial statements of Endava plc and subsidiaries as of and for the years ended June 30, 2022, 202 |
|
October 31, 2022 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Endava plc (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Security Type Security Class Title(1) Fee Calculation Rule Amount Registered(2) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Class A ordinary shares, nominal value ?0. |
|
October 31, 2022 |
Exhibit 12.1 Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, John Cotterell, certify that: 1. I have reviewed this annual report on Form 20-F of ENDAVA PLC (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a materia |
|
October 6, 2022 |
Endava Announces the Acquisition of Lexicon, Australia Endava Announces the Acquisition of Lexicon, Australia London, UK, October 6, 2022, (NYSE ?DAVA?) Endava announced today the acquisition of Lexicon Digital Pty Ltd and Lexicon Consolidated Holdings Pty Ltd, headquartered in Melbourne, Australia (?Lexicon?). |
|
October 6, 2022 |
6-K 1 endava-projectamigapressre.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of October 2022 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive offi |
|
September 29, 2022 |
Jaime L. Chase +1 202 728 7096 [email protected] Via EDGAR September 29, 2022 U.S. Securities and Exchange Commission Office of Life Sciences Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Brittany Ebbertt Kathleen Collins Stephanie Sullivan Re: Endava plc. Amendment to Annual Report on Form 20-F (File No. 001-38607) Filed on September 28, 2021 CIK 0001656081 |
|
September 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of September 2022 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the |
|
September 27, 2022 |
Q4 FY2022 INVESTOR PRESENTATION 2 This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
September 27, 2022 |
Q4 FY2022 & FY2022 ENDAVA ANNOUNCES FOURTH QUARTER FISCAL YEAR 2022 & FISCAL YEAR 2022 RESULTS Q4 FY2022 35. |
|
September 12, 2022 |
Jaime L. Chase +1 202 728 7096 [email protected] Via EDGAR September 12, 2022 U.S. Securities and Exchange Commission Office of Life Sciences Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Brittany Ebbertt Kathleen Collins Stephanie Sullivan Re: Endava plc. Amendment to Annual Report on Form 20-F (File No. 001-38607) Filed on September 28, 2021 CIK 0001656081 |
|
August 24, 2022 |
Jaime L. Chase T: +1 202 728 7096 [email protected] August 24, 2022 United States Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street, N.E. Washington, D.C. 20549 Attn: Brittany Ebbert Kathleen Collins Re: Endava plc Form 20-F for the Fiscal Year Ended June 30, 2021 Filed September 28, 2021 File No. 001-38607 Ladies and Gentlemen: Reference is made |
|
May 12, 2022 |
6-K 1 a6-kq3fy22.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2022 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by chec |
|
May 12, 2022 |
Q3 FY2022 INVESTOR PRESENTATION 2 This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
May 12, 2022 |
Q3 FY2022 ENDAVA ANNOUNCES THIRD QUARTER FISCAL YEAR 2022 RESULTS Q3 FY2022 50.7% Year on Year Revenue Growth to ?169.2 million 50.9% Revenue Growth at Constant Currency IFRS diluted EPS ?0.35 compared to ?0.23 in the prior year comparative period Adjusted diluted EPS ?0.48 compared to ?0.34 in the prior year comparative period London, U.K. ? Endava plc (NYSE: DAVA) ("Endava" or the "Company") a g |
|
March 30, 2022 |
The following risk factors update and supplement, and should be read together with, the risk factors previously provided under ?Risk Factors? in Part I, Item 3. |
|
March 30, 2022 |
ENDAVA PLC CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) For the six months ended December 31, 2021 and 2020 Six Months Ended December 31 2021 2020 (1) Note ??000 ??000 REVENUE 5 305,133 200,365 Cost of sales Direct cost of sales (189,292) (120,479) Allocated cost of sales (11,090) (9,912) Total cost of sales (200,382) (130,391) GROSS PROFIT 104,751 69,974 Selling, general |
|
March 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of March 2022 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the regi |
|
February 16, 2022 |
Q2 FY2022 INVESTOR PRESENTATION 2 This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
February 16, 2022 |
Q2 FY2022 ENDAVA ANNOUNCES SECOND QUARTER FISCAL YEAR 2022 RESULTS Q2 FY2022 49.8% Year on Year Revenue Growth to ?157.7 million 53.4% Revenue Growth at Constant Currency IFRS diluted EPS ?0.27 compared to ?0.14 in the prior year comparative period Adjusted diluted EPS ?0.46 compared to ?0.29 in the prior year comparative period London, U.K. ? Endava plc (NYSE: DAVA) ("Endava" or the "Company") a |
|
February 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of February 2022 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
February 14, 2022 |
DAVA / Endava PLC - ADR / BAMCO INC /NY/ - NONE Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Endava plc (Name of Issuer) AMERICAN DEPOSITARY SHARES (Title of Class of Securities) 29260V105*** (CUSIP Number) Calendar Year 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
February 14, 2022 |
DAVA / Endava PLC - ADR / Cotterell John - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Endava plc (Name of Issuer) Class A ordinary shares, nominal value ?0.02 per ordinary share (Title of Class of Securities) 29260V105** (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
December 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of December 2021 Commission File Number: 001-38607 ENDAVA PLC (Translation of registrant?s name into English) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate |
|
November 16, 2021 |
Q1 FY2022 ENDAVA ANNOUNCES FIRST QUARTER FISCAL YEAR 2022 RESULTS Q1 FY2022 55.0% Year on Year Revenue Growth to ?147.5 million 60.8% Revenue Growth at Constant Currency IFRS diluted EPS ?0.36 compared to ?0.12 in the prior year comparative period Adjusted diluted EPS ?0.49 compared to ?0.26 in the prior year comparative period London, U.K. ? Endava plc (NYSE: DAVA) ("Endava" or the "Company") a g |
|
November 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2021 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
November 16, 2021 |
Q1 FY2022 INVESTOR PRESENTATION 2 This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
November 10, 2021 |
Annual General Meeting The Voting Instructions must be signed, completed and received at the indicated address prior to 10:00 A. |
|
November 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2021 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
November 10, 2021 |
Time Sensitive Materials Depositary?s Notice of Annual General Meeting of Endava plc (the ?Company?) ADSs: American Depositary Shares. |
|
November 10, 2021 |
Class A Ordinary Shares Beneficially Owned THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to the action to be taken, please seek your own financial advice from your stockbroker, solicitor, accountant or other appropriately authorised independent financial adviser. If you have recently sold or transferred all of your shares in Endava plc (?Endava?, or the ?Company?) you should forward this docum |
|
September 30, 2021 |
As filed with the Securities and Exchange Commission on September 30, 2021 As filed with the Securities and Exchange Commission on September 30, 2021 Registration No. |
|
September 28, 2021 |
Consent of KPMG LLP, independent registered public accounting firm Exhibit 15.1 Consent of Independent Registered Public Accounting Firm The Board of Directors Endava plc: We consent to the incorporation by reference in the registration statements (No. 333-228717) on Form S-8 and (No. 333-229213) on Form F-3 of our reports dated September 28, 2021, with respect to the consolidated financial statements of Endava plc and the effectiveness of internal control over f |
|
September 28, 2021 |
6-K 1 a6-kq4fy21.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of September 2021 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate b |
|
September 28, 2021 |
Q4 FY2021 & FY2021 ENDAVA ANNOUNCES FOURTH QUARTER FISCAL YEAR 2021 & FISCAL YEAR 2021 RESULTS Q4 FY2021 47. |
|
September 28, 2021 |
Exhibit 12.1 Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, John Cotterell, certify that: 1. I have reviewed this annual report on Form 20-F of ENDAVA PLC (the ?Company?); 2. Based on my knowledge, this report does not contain any untrue statement of a materia |
|
September 28, 2021 |
Q4 FY2021 INVESTOR PRESENTATION 2 This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
September 28, 2021 |
Exhibit 12.2 Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Mark Thurston, certify that: 1. I have reviewed this annual report on Form 20-F of ENDAVA PLC (the ?Company?); 2. Based on my knowledge, this report does not contain any untrue statement of a material |
|
September 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 20-F (Mark One) ? REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934 For the fiscal year ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF |
|
September 28, 2021 |
EX-99.3 4 esgreportpressreleaseendav.htm EX-99.3 ENDAVA LAUNCHES WE CARE SUSTAINABILITY REPORT Endava showcases its positive impact on its people and customers, as well as its contributions to the communities where it operates. The report outlines Endava’s five areas of focus that bring its sustainability mission to life. London, UK (September 28, 2021) – Today Endava plc (NYSE: DAVA), a leading n |
|
September 28, 2021 |
Exhibit 13.1 Certification by the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 |
|
May 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2021 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the regist |
|
May 19, 2021 |
Q3 FY2021 ENDAVA ANNOUNCES THIRD QUARTER FISCAL YEAR 2021 RESULTS Q3 FY2021 21.8% Year on Year Revenue Growth to ?112.3 million 23.8% Revenue Growth at Constant Currency IFRS diluted EPS ?0.23 compared to ?0.26 in the prior year comparative period Adjusted diluted EPS ?0.34 compared to ?0.23 in the prior year comparative period London, U.K. ? Endava plc (NYSE: DAVA) ("Endava" or the "Company") a g |
|
May 19, 2021 |
Q3 FY2021 INVESTOR PRESENTATION 2 This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
April 1, 2021 |
Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of April 2021 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the regi |
|
April 1, 2021 |
Endava Announces the Acquisition of Levvel LLC Endava Announces the Acquisition of Levvel LLC London, UK, April 1, 2021, (NYSE ?DAVA?) Endava announced today the acquisition of Levvel LLC, headquartered in Charlotte N. |
|
March 30, 2021 |
Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of March 2021 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the regi |
|
March 30, 2021 |
ENDAVA PLC CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) For the six months ended December 31, 2020 and 2019 Six Months Ended December 31 2020 2019 Note £’000 £’000 REVENUE 5 200,365 168,252 Cost of sales Direct cost of sales (120,479) (122,592) Allocated cost of sales (9,912) (8,311) Total cost of sales (130,391) (130,903) GROSS PROFIT 69,974 37,349 Selling, general and ad |
|
March 4, 2021 |
Endava Announces the Acquisition of Pet Minuta EX-99.1 2 endavapressrelease-project.htm EX-99.1 Endava Announces the Acquisition of Pet Minuta London, UK, March 4, 2021, (NYSE “DAVA”) Endava announced today the acquisition of Pet Minuta d.o.o. of Croatia and its U.S. subsidiary, Five Minutes Studio, Inc. (together “FIVE”). FIVE, based in Brooklyn, NY and Croatia, is a digital agency delivering a full spectrum of services, including product str |
|
March 4, 2021 |
Current Report of Foreign Issuer - 6-K 6-K 1 endava6kprojectfirestonepr.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of March 2021 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office |
|
February 17, 2021 |
Q2 FY2021 ENDAVA ANNOUNCES SECOND QUARTER FISCAL YEAR 2021 RESULTS Q2 FY2021 22.5% Year on Year Revenue Growth to ?105.2 million 21.4% Revenue Growth at Constant Currency IFRS diluted EPS ?0.14 compared to ?(0.25) in the prior year comparative period Adjusted diluted EPS ?0.29 compared to ?0.30 in the prior year comparative period London, U.K. ? Endava plc (NYSE: DAVA) ("Endava" or the "Company") |
|
February 17, 2021 |
Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of February 2021 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
February 17, 2021 |
Q2 FY2021 INVESTOR PRESENTATION 2 This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
February 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Endava plc (Name of Issuer) Class A ordinary shares, nominal value ?0.02 per ordinary share (Title of Class of Securities) 29260V105** (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
February 11, 2021 |
SC 13G/A 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Endava plc (Name of Issuer) AMERICAN DEPOSITARY SHARES (Title of Class of Securities) 29260V105*** (CUSIP Number) Calendar Year 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate t |
|
February 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* ENDAVA PLC (Name of Issuer) Depository Receipt (Title of Class of Securities) 29260V105 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
February 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Endava plc (Name of Issuer) Class A ordinary shares, nominal value £0.02 per ordinary share (Title of Class of Securities) 29260V105** (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
February 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Endava plc (Name of Issuer) Class A ordinary shares, nominal value £0.02 per ordinary share (Title of Class of Securities) 29260V105** (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
February 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Endava plc (Name of Issuer) Class A ordinary shares, nominal value £0.02 per ordinary share (Title of Class of Securities) 29260V105** (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
February 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Endava plc (Name of Issuer) Class A ordinary shares, nominal value £0.02 per ordinary share (Title of Class of Securities) 29260V105** (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
December 17, 2020 |
Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2020 Commission File Number: 001-38607 ENDAVA PLC (Translation of registrant’s name into English) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate |
|
November 18, 2020 |
ENDAVA PLC Endava plc is incorporated and registered in England and Wales under the Companies Act 2006, with company number 5722669. |
|
November 18, 2020 |
Time Sensitive Materials Depositary’s Notice of Annual General Meeting of Endava plc (the “Company”) ADSs: American Depositary Shares. |
|
November 18, 2020 |
Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2020 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
November 18, 2020 |
Annual General Meeting The Voting Instructions must be signed, completed and received at the indicated address prior to 10:00 A. |
|
November 18, 2020 |
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to the action to be taken, please seek your own financial advice from your stockbroker, solicitor, accountant or other appropriately authorised independent financial adviser. If you have recently sold or transferred all of your shares in Endava plc (“Endava” or the “Company”), you should forward this docum |
|
November 12, 2020 |
Q1 FY2021 ENDAVA ANNOUNCES FIRST QUARTER FISCAL YEAR 2021 RESULTS Q1 FY2021 15.5% Year on Year Revenue Growth to £95.1 million 16.9% Revenue Growth at Constant Currency IFRS diluted EPS £0.12 compared to £0.26 in the prior year comparative period Adjusted diluted EPS £0.26 compared to £0.24 in the prior year comparative period London, U.K. – Endava plc (NYSE: DAVA) ("Endava" or the "Company") a gl |
|
November 12, 2020 |
Current Report of Foreign Issuer - 6-K 6-K 1 a6-kq1fy21.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2020 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by |
|
November 12, 2020 |
irq1fy21final INVESTOR PRESENTATION Q1 FY2021 Disclaimer This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
October 16, 2020 |
DAVA / Endava plc / Grandeur Peak Global Advisors, LLC - ENDAVA PLC SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Endava PLC (Name of Issuer) American Depository Shares (Title of Class of Securities) 29260V105* (CUSIP Number) September 15, 2020 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fil |
|
September 18, 2020 |
As filed with the Securities and Exchange Commission on September 18, 2020 Registration No. |
|
September 15, 2020 |
Q4 FY2020 & FY2020 ENDAVA ANNOUNCES FOURTH QUARTER FISCAL YEAR 2020 & FISCAL YEAR 2020 RESULTS Q4 FY2020 18. |
|
September 15, 2020 |
Exhibit 12.1 Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, John Cotterell, certify that: 1. I have reviewed this annual report on Form 20-F of ENDAVA PLC (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a materia |
|
September 15, 2020 |
Exhibit 12.2 Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Mark Thurston, certify that: 1. I have reviewed this annual report on Form 20-F of ENDAVA PLC (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material |
|
September 15, 2020 |
Exhibit 4.12 [***] = Certain information contained in this document, marked by brackets, has been omitted because it is both not material and would be competitively harmful if publicly disclosed. Execution version SHARE PURCHASE AGREEMENT COMTRADE GROUP B.V. COMTRADE SOLUTIONS MANAGEMENT HOLDINŠKA DRUŽBA D.O.O. (as Sellers) ENDAVA (UK) LIMITED (as Purchaser) relating to the sale and purchase of th |
|
September 15, 2020 |
Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of September 2020 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the |
|
September 15, 2020 |
Exhibit 13.1 Certification by the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 |
|
September 15, 2020 |
Consent of KPMG LLP, independent registered public accounting firm EX-15.1 8 exhibit151fy20.htm EXHIBIT 15.1 Exhibit 15.1 Consent of Independent Registered Public Accounting Firm The Board of Directors Endava plc: We consent to the incorporation by reference in the registration statements on Form S-8 (File No. 333-228717) and Form F-3 (File No. 333-229213) of Endava plc of our reports dated September 15, 2020, with respect to the consolidated balance sheets of En |
|
September 15, 2020 |
Exhibit 2.3(a) DESCRIPTION OF SHARE CAPITAL The following summarizes the material provisions of our articles of association and highlights certain differences in corporate law in the United Kingdom and the United States. Please note that this summary is not intended to be exhaustive. For further information, please refer to the full version of our articles of association, which are included as an |
|
September 15, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 20-F (Mark One) ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934 For the fiscal year ended June 30, 2020 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF |
|
September 15, 2020 |
irq4fy20final INVESTOR PRESENTATION Q4 FY2020 Disclaimer This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
August 17, 2020 |
Endava Announces the Acquisition of Comtrade Digital Services Endava Announces the Acquisition of Comtrade Digital Services London, UK, August 17, 2020 (NYSE “DAVA”) Endava plc (“Endava”) announced today the acquisition of the Comtrade Digital Services business (“CDS”). |
|
August 17, 2020 |
Current Report of Foreign Issuer - 6-K 6-K 1 endava6kprojectcrystalpres.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of August 2020 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive offic |
|
July 10, 2020 |
DAVA / Endava plc / BAMCO INC /NY/ - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Endava plc (Name of Issuer) AMERICAN DEPOSITARY SHARES (Title of Class of Securities) 29260V105*** (CUSIP Number) June 30, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
July 9, 2020 |
DAVA / Endava plc / BAMCO INC /NY/ - NONE Passive Investment SC 13G/A 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Endava plc (Name of Issuer) AMERICAN DEPOSITARY SHARES (Title of Class of Securities) 29260V105*** (CUSIP Number) June 30, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru |
|
May 21, 2020 |
INVESTOR PRESENTATION Q3 FY2020 Disclaimer This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
May 21, 2020 |
Q3 FY2020 ENDAVA ANNOUNCES THIRD QUARTER FISCAL YEAR 2020 RESULTS Q3 FY2020 26.2%Year on Year Revenue Growth to £92.2 million 25.7% Revenue Growth at Constant Currency IFRS diluted EPS £0.26 compared to £0.11 in the prior year comparative period Adjusted diluted EPS £0.23 compared to £0.19 in the prior year comparative period London, U.K. – Endava plc (NYSE: DAVA) ("Endava" or the "Company") a glo |
|
May 21, 2020 |
Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2020 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the regist |
|
April 29, 2020 |
DAVA / Endava plc / Grandeur Peak Global Advisors, LLC - ENDAVA PLC SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Endava PLC (Name of Issuer) American Depository Shares (Title of Class of Securities) 29260V105* (CUSIP Number) March 13, 2020 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
|
March 31, 2020 |
The following risk factors update and supplement, and should be read together with, the risk factors previously provided under “Risk Factors” in Part I, Item 3. |
|
March 31, 2020 |
DAVA / Endava plc 6-K - Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of March 2020 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the regi |
|
March 31, 2020 |
ENDAVA PLC CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) For the six months ended December 31, 2019 and 2018 Six Months Ended December 31 2019 2018 Note £’000 £’000 REVENUE 5 168,252 138,248 Cost of sales Direct cost of sales (122,592 ) (83,026 ) Allocated cost of sales (8,311 ) (7,305 ) Total cost of sales 14 (130,903 ) (90,331 ) GROSS PROFIT 37,349 47,917 Selling, general |
|
February 18, 2020 |
DAVA / Endava plc / BAMCO INC /NY/ - NONE Passive Investment SC 13G 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* Endava plc (Name of Issuer) AMERICAN DEPOSITARY SHARES (Title of Class of Securities) 29260V105*** (CUSIP Number) Calendar Year 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate |
|
February 14, 2020 |
DAVA / Endava plc / Day Alex - SC 13G Passive Investment SC 13G 1 endava-day202013g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Endava plc (Name of Issuer) Class A ordinary shares, nominal value £0.02 per ordinary share (Title of Class of Securities) 29260V105** (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Sta |
|
February 14, 2020 |
DAVA / Endava plc / Cotterell John - SC 13G Passive Investment SC 13G 1 endava-cotterell202013g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.1)* Endava plc (Name of Issuer) Class A ordinary shares, nominal value £0.02 per ordinary share (Title of Class of Securities) 29260V105** (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of thi |
|
February 14, 2020 |
DAVA / Endava plc / MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* ENDAVA PLC (Name of Issuer) Depository Receipt (Title of Class of Securities) 29260V105 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
February 14, 2020 |
DAVA / Endava plc / Heron David - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Endava plc (Name of Issuer) Class A ordinary shares, nominal value £0.02 per ordinary share (Title of Class of Securities) 29260V105** (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
February 14, 2020 |
DAVA / Endava plc / Endava Ltd Guernsey Employee Benefit Trust - SC 13G Passive Investment SC 13G 1 ebtschedule13g2020.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Endava plc (Name of Issuer) Class A Ordinary shares, nominal value £0.02 per ordinary share (Title of Class of Securities) 29260V105** (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this St |
|
February 13, 2020 |
irdeckfeb2020 INVESTOR PRESENTATION Q2 FY2020 DISCLAIMER This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
February 13, 2020 |
Q2 FY2020 ENDAVA ANNOUNCES SECOND QUARTER FISCAL YEAR 2020 RESULTS Q2 FY2020 19.6%Year on Year Revenue Growth to £85.9 million 20.5% Revenue Growth at Constant Currency IFRS diluted EPS £(0.25) compared to £0.14 in the prior year comparative period Adjusted diluted EPS £0.30 compared to £0.20 in the prior year comparative period London, U.K. – Endava plc (NYSE: DAVA) ("Endava" or the "Company") a |
|
February 13, 2020 |
DAVA / Endava plc 6-K - Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of February 2020 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
December 17, 2019 |
Endava Announces the Acquisition of Exozet GmbH Endava Announces the Acquisition of Exozet GmbH London, UK, December 17, 2019 (NYSE “DAVA”) Endava announced today the acquisition of Exozet GmbH (“Exozet”), headquartered in Berlin, Germany. |
|
December 17, 2019 |
DAVA / Endava plc 6-K - Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of December 2019 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
December 10, 2019 |
DAVA / Endava plc 6-K - Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of December 2019 Commission File Number: 001-38607 ENDAVA PLC (Translation of registrant’s name into English) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate |
|
November 19, 2019 |
irdeckq1fy20final INVESTOR PRESENTATION Q1 FY2020 DISCLAIMER This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
November 19, 2019 |
DAVA / Endava plc 6-K - Current Report of Foreign Issuer - 6-K 6-K 1 a6-kq1fy201.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2019 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate b |
|
November 19, 2019 |
Q1 FY2020 ENDAVA ANNOUNCES FIRST QUARTER FISCAL YEAR 2020 RESULTS Q1 FY2020 24.0% Year on Year Revenue Growth to £82.4 million 21.5% Revenue Growth at Constant Currency IFRS diluted EPS £0.26 compared to £0.04 in the prior year comparative period Adjusted diluted EPS £0.24 compared to £0.17 in the prior year comparative period London, U.K. – Endava plc (NYSE: DAVA) ("Endava" or the "Company") a gl |
|
November 6, 2019 |
a994e619133endavacardfin Annual General Meeting The Voting Instructions must be signed, completed and received at the indicated address prior to 10:00 A. |
|
November 6, 2019 |
EX-99.3 4 a993e619133endavanoticef.htm EXHIBIT 99.3 Time Sensitive Materials Depositary’s Notice of Annual General Meeting of Endava plc ADSs: American Depositary Shares. ADS CUSIP No.: 29260V105. ADS Record Date: October 31, 2019. Meeting Specifics: Annual General Meeting to be held on Monday, December 9, 2019 at 2:30 P.M. (Greenwich Mean Time) at the offices of Cooley (UK) LLP at 69 Old Broad St |
|
November 6, 2019 |
a991endavaagmnotice2019 THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. |
|
November 6, 2019 |
DAVA / Endava plc 6-K - Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2019 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
November 6, 2019 |
a992endavaagmproxyform20 ENDAVA PLC Endava plc is incorporated and registered in England and Wales under the Companies Act 2006, with company number 5722669. |
|
November 4, 2019 |
1,906,462 American Depositary Shares REPRESENTING 1,906,462 CLASS A ORDINARY SHARES Filed Pursuant to Rule 424(b)(3) Registration No. 333-229213 PROSPECTUS 1,906,462 American Depositary Shares REPRESENTING 1,906,462 CLASS A ORDINARY SHARES The Endava Limited Guernsey Employee Benefit Trust, or the EBT, is offering 1,906,462 American Depositary Shares, or ADSs. Each ADS represents one Class A Ordinary Share. The ADSs may be evidenced by American Depositary Receipts, or ADRs. We ha |
|
November 4, 2019 |
Endava Announces the Acquisition of Intuitus Limited Endava Announces the Acquisition of Intuitus Limited London, UK, November 4, 2019 (NYSE “DAVA”) Endava announced today the purchase of Intuitus Limited (“Intuitus”), headquartered in Edinburgh, Scotland. |
|
November 4, 2019 |
DAVA / Endava plc 6-K - Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2019 Commission File Number: 001-38607 ENDAVA PLC (Name of Registrant) 125 Old Broad Street London EC2N 1AR (Address of principal executive office) Indicate by check mark whether the r |
|
October 18, 2019 |
DAVA / Endava plc POS AM - - F-3 As filed with the Securities and Exchange Commission on October 18, 2019. Registration No. 333-229213 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 2 ON FORM F-3 TO REGISTRATION STATEMENT ON FORM F-1 UNDER THE SECURITIES ACT OF 1933 ENDAVA PLC (Exact Name of Registrant as Specified in its Charter) England and Wales Not Applicable (State or oth |
|
October 15, 2019 |
Multicurrency Revolving Facility Agreement Between ENDAVA PLC as Company ENDAVA PLC ENDAVA (UK) LIMITED ENDAVA INC as Original Borrowers ENDAVA PLC ENDAVA (UK) LIMITED ENDAVA INC ENDAVA LLC as Original Guarantors HSBC UK BANK PLC DNB (UK) LIMITED KEYBANK NATIONAL ASSOCIATION SILICON VALLEY BANK as Mandated Lead Arrangers and Bookrunners HSBC UK BANK PLC DNB (UK) LIMITED KEYBANK NATIONAL ASSOCIATION SILICON VALLEY BANK as Original Lenders and HSBC BANK PLC as Agent CONTENTS 1. |